Tag: GPX embolic
Fluidx Medical announces first patient treated in prospective trial
Fluidx Medical has announced that the first patient has been treated in the GPX investigational device exception (IDE) prospective multinational clinical trial.
The GPX...
Fluidx Medical announces US FDA approval for embolic device clinical trial
Fluidx Medical Technology has announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval to initiate the GPX...
New embolic device demonstrates superior vessel filling in tumour models
Fluidx Medical disclosed study results examining extent of vessel filling using the GPX embolic device compared to microspheres, a common treatment for many types...
Fluidx Medical’s embolic device demonstrates promising visibility
Fluidx Medical Technology has announced the results of the GPX-Clear embolic device in-vivo research which uses the base GPX technology and incorporates an intermediate-term...
Novel embolic device used for arterial and venous tumour treatments
Fluidx Medical Technology has announced that GPX Embolic Device first patient use cases were presented at LINC 2021 (25–29 January, online).
“This is very promising...
First use of new embolic device for highly targeted tumour treatment...
A novel embolization device in the interventional oncology space—the GPX embolic device (Fluidx Medical Technology)—has successfully been used in a patient to therapeutically devascularise...
